If you use it for a much longer period of time than you would potentially use other GLP-1s for, then over time it could ultimately cost you more
SHBG helps estimate free androgen status, DHEAS points more toward an adrenal source of androgen excess, and androstenedione can suggest ovarian contribution
Melanotan II is associated with a wide range of serious and potentially life-threatening side effects
Lastly, for patients with significant high-end metabolic issues, sleep apnea, heart disease, uncontrolled hypertension, or immobility due to high BMI, GLP-1s alone may not be enough
Strategies to use GDNF gene vectors have not been successfully so far (Van Laar et al., 2021)